99 A. C. M. Jansen et al., “The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.” Journal of Internal Medicine 256, no. 6 (December 2004): 482–90.

100 R. Champeau, “Most heart attack patients’ cholesterol levels did not indicate cardiac risk.” newsroom.ucla.edu, January 12, 2009.

101 A. C. M. Jansen et al., “Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.” Arteriosclerosis, Thrombosis, and Vascular Biology 25, no. 7 (July 2005): 1475–81.

102 P. K. Elias et al., “Serum cholesterol and cognitive performance in the Framingham Heart Study.” Psychosomatic Medicine 67, no. 1 (January 2005): 24–30.

103 A. W. Weverling-Rijnsburger et al., “Total cholesterol and risk of mortality in the oldest old.” Lancet 350, no. 9085 (October 1997): 1119–23.

104 Y. Takata et al., “Serum total cholesterol concentration and 10-year mortality in an 85-year-old population.” Clinical Interventions in Aging 9 (January 2014): 293–300.

105 L. M. L. de Lau et al., “Serum cholesterol levels and the risk of Parkinson’s disease.” American Journal of Epidemiology 164, no. 10 (November 2006): 998–1002.

106 L. Dupuis et al., “Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.” Neurology 70, no. 13 (March 2008): 1004–9.

107 X. Huang et al., “Low LDL cholesterol and increased risk of Parkinson’s disease: prospective results from Honolulu-Asia Aging Study.” Movement Disorders: Official Journal of the Movement Disorder Society 23, no. 7 (May 2008): 1013–18.

108 D. S. Ng et al., “HDL – is it too big to fail?” Nature Reviews Endocrinology 9, no. 5 (May 2013): 308–12.